Guardion Health Sciences, Inc.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Guardion Health Sciences, Inc. (Nasdaq: GHSI) operates as a clinical nutrition company that develops and distributes clinically supported dietary supplements, medical foods, and medical devices focused on ocular health and nutraceuticals; key products include GlaucoCetin, a dietary supplement supporting mitochondrial function with antioxidants to reduce oxidative stress, enhance blood flow, and promote eye health; Lumega-Z, a medical food replenishing macular protective pigment; medical devices such as MapcatSF, CSV-1000, and CSV-2000 for vision assessment; and nutraceuticals under brands including NutriGuard and formerly Viactiv soft calcium chews, omega-3 supplements, and multivitamins. The company targets healthcare professionals, patients with age-related macular degeneration and related conditions, and general consumers seeking nutritional support, with distribution through e-commerce platforms like guardionhealth.com across North America, Europe, and international markets. Founded in 2009 and headquartered in Houston, Texas, Guardion recently completed the sale of its Viactiv brand and business to Doctor's Best Inc. in May 2024 for approximately $17.2 million, enabling a strategic focus on core medical foods and devices; adopted a plan of complete liquidation and dissolution in October 2024 with stockholder approval, filed a certificate of dissolution on October 30, 2024, declared a cash distribution to stockholders, voluntarily delisted from Nasdaq, and suspended SEC reporting obligations as it winds down operations.
Guardion Health Sciences Announces Declaration of Cash Distribution
Guardion Health Sciences Announces Filing of Certificate of Dissolution
Guardion Health Sciences Declares Cash Dividend of $5.00 Per Share of Common Stock
Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2024
Guardion Health Sciences Announces Completion of Sale of its Viactiv® Brand and Business to Doctor's Best Inc. and Stockholder Approval of Plan of Liquidation and Dissolution
Guardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv Business
Guardion Health Sciences Announces
Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023
Why Is Guardion Health (GHSI) Stock Up 66% Today?
What made Guardion Health stock double on Wednesday?
Guardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv® Brand and Business to Doctor's Best Inc.
Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2023
Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2023
7 Penny Stocks That Actually Have Buy Ratings
7 Undervalued Penny Stocks to Buy for Massive Gains
Best Penny Stocks to Watch as the Market Turns Bullish Today
Guardion Health Sciences to Present at the Planet MicroCap Showcase 2022
4 Top Penny Stocks To Buy For Under $1 This Week
Trading Penny Stocks? Top Stock Market News for March 2nd, 2022
Hot Penny Stocks To Buy For Under $1 In March 2022